High dose levetiracetam
Small molecule
High dose levetiracetam is one of 7 small molecule programs targeting Neonatal seizure. It is currently in development.
1
Indications
1
Total Trials
0
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Neonatal Seizure
#DrugCompanyPhaseTrials
1Vimpat
UCBPhase 2
Bumex
VValidus Pharmaceuticals
Phase 2
Keppra
UCBPreclinical
Low Dose Valproate
Mario Negri Institute for Pharmacological ResearchPhase 2
Luminal
BBiomed Industries, Inc.
Preclinical
Phenobarbital Sodium
UUniversity of California, San Diego
Preclinical
High dose levetiracetam
RRichard H. Haas
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for High dose levetiracetam. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company
- RRichard H. Haas